| Item Type | Name |
|
Academic Article
|
Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas.
|
|
Academic Article
|
FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
|
|
Academic Article
|
Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin.
|
|
Academic Article
|
Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
|
|
Academic Article
|
Chromosome 10 alterations in prostate adenocarcinoma (review).
|
|
Academic Article
|
Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
|
|
Academic Article
|
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.
|
|
Academic Article
|
Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
|
|
Academic Article
|
Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia.
|
|
Academic Article
|
Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
|
|
Academic Article
|
Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
|
|
Academic Article
|
In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptor.
|
|
Academic Article
|
Allelic loss on chromosome 13q in human prostate carcinoma.
|
|
Academic Article
|
Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma.
|
|
Academic Article
|
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.
|
|
Academic Article
|
Role of fibroblast growth factor receptor signaling in prostate cancer cell survival.
|
|
Academic Article
|
RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer.
|
|
Academic Article
|
FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
|
|
Academic Article
|
Androgen receptor mutations in prostate cancer.
|
|
Academic Article
|
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
|
|
Academic Article
|
FGF-10 is expressed at low levels in the human prostate.
|
|
Academic Article
|
PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer.
|
|
Academic Article
|
Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice.
|
|
Academic Article
|
Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
|
|
Academic Article
|
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
|
|
Academic Article
|
Increased expression of the metastasis-associated gene Ehm2 in prostate cancer.
|
|
Academic Article
|
Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia.
|
|
Academic Article
|
Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
|
|
Academic Article
|
Relaxin promotes prostate cancer progression.
|
|
Academic Article
|
Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.
|
|
Academic Article
|
Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.
|
|
Academic Article
|
Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
|
|
Academic Article
|
Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts.
|
|
Academic Article
|
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
|
|
Academic Article
|
Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.
|
|
Academic Article
|
Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia.
|
|
Academic Article
|
Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
|
|
Academic Article
|
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
|
|
Academic Article
|
The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.
|
|
Academic Article
|
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.
|
|
Academic Article
|
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
|
|
Academic Article
|
The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo.
|
|
Academic Article
|
Mutation of the androgen receptor causes oncogenic transformation of the prostate.
|
|
Academic Article
|
The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
|
|
Academic Article
|
Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer.
|
|
Academic Article
|
Activation of Wnt signaling by chemically induced dimerization of LRP5 disrupts cellular homeostasis.
|
|
Academic Article
|
Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation.
|
|
Academic Article
|
SRC-3 is required for prostate cancer cell proliferation and survival.
|
|
Academic Article
|
Bystin in perineural invasion of prostate cancer.
|
|
Academic Article
|
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer.
|
|
Academic Article
|
Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.
|
|
Academic Article
|
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.
|
|
Academic Article
|
Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.
|
|
Academic Article
|
Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer.
|
|
Academic Article
|
Widespread deregulation of microRNA expression in human prostate cancer.
|
|
Academic Article
|
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
|
|
Academic Article
|
Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.
|
|
Academic Article
|
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
|
|
Academic Article
|
Cancer-related axonogenesis and neurogenesis in prostate cancer.
|
|
Academic Article
|
DNA methylation and aberrant expression of Sprouty1 in human prostate cancer.
|
|
Academic Article
|
GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression.
|
|
Academic Article
|
Genomic profiling of prostate cancers from African American men.
|
|
Academic Article
|
DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy.
|
|
Academic Article
|
Relaxin/RXFP1 signaling in prostate cancer progression.
|
|
Academic Article
|
Global gene expression analysis of reactive stroma in prostate cancer.
|
|
Academic Article
|
Dicer ablation impairs prostate stem cell activity and causes prostate atrophy.
|
|
Academic Article
|
The function of microRNAs, small but potent molecules, in human prostate cancer.
|
|
Academic Article
|
Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing.
|
|
Academic Article
|
Common structural and epigenetic changes in the genome of castration-resistant prostate cancer.
|
|
Academic Article
|
TGF-?1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse.
|
|
Academic Article
|
Frequent heterogeneous missense mutations of GGAP2 in prostate cancer: implications for tumor biology, clonality and mutation analysis.
|
|
Academic Article
|
Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.
|
|
Academic Article
|
SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.
|
|
Academic Article
|
Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression.
|
|
Academic Article
|
COUP-TFII inhibits TGF-?-induced growth barrier to promote prostate tumorigenesis.
|
|
Academic Article
|
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
|
|
Academic Article
|
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.
|
|
Academic Article
|
Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.
|
|
Academic Article
|
Allelic loss on chromosome 10 in prostate adenocarcinoma.
|
|
Academic Article
|
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
|
|
Academic Article
|
Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
|
|
Academic Article
|
Elevated caveolin-1 levels in African-American versus white-American prostate cancer.
|
|
Academic Article
|
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.
|
|
Academic Article
|
Interleukin-6 is an autocrine growth factor in human prostate cancer.
|
|
Academic Article
|
The role of caveolin-1 in androgen insensitive prostate cancer.
|
|
Academic Article
|
Cellular senescence in the pathogenesis of benign prostatic hyperplasia.
|
|
Academic Article
|
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.
|
|
Academic Article
|
Glutathione S-transferase pi is upregulated in the stromal compartment of hormone independent prostate cancer.
|
|
Academic Article
|
Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
|
|
Academic Article
|
Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.
|
|
Academic Article
|
Growth and survival mechanisms associated with perineural invasion in prostate cancer.
|
|
Academic Article
|
The role of fibroblast growth factors and their receptors in prostate cancer.
|
|
Academic Article
|
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.
|
|
Academic Article
|
A working group classification of focal prostate atrophy lesions.
|
|
Academic Article
|
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
|
|
Academic Article
|
Age-related DNA methylation changes in normal human prostate tissues.
|
|
Academic Article
|
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
|
|
Academic Article
|
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.
|
|
Academic Article
|
Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk.
|
|
Academic Article
|
FGFR-4 Arg?88 enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.
|
|
Academic Article
|
Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer.
|
|
Academic Article
|
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
|
|
Academic Article
|
GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
|
|
Academic Article
|
Notch and TGF? form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity.
|
|
Academic Article
|
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.
|
|
Academic Article
|
Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort.
|
|
Academic Article
|
FGFR1 is essential for prostate cancer progression and metastasis.
|
|
Concept
|
Prostate
|
|
Concept
|
Prostate-Specific Antigen
|
|
Academic Article
|
ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.
|
|
Academic Article
|
The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.
|
|
Academic Article
|
Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
|
|
Academic Article
|
Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer.
|
|
Academic Article
|
Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.
|
|
Academic Article
|
Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.
|
|
Academic Article
|
Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.
|
|
Academic Article
|
Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
|
|
Academic Article
|
HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.
|
|
Academic Article
|
FGFR1-WNT-TGF-? signaling in prostate cancer mouse models recapitulates human reactive stroma.
|
|
Academic Article
|
The senescence-associated secretory phenotype promotes benign prostatic hyperplasia.
|
|
Academic Article
|
A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis.
|
|
Academic Article
|
miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer.
|
|
Academic Article
|
Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells.
|
|
Academic Article
|
The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
|
|
Academic Article
|
Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
|
|
Academic Article
|
Stromal TGF-? signaling induces AR activation in prostate cancer.
|
|
Academic Article
|
Androgens regulate prostate cancer cell growth via an AMPK-PGC-1a-mediated metabolic switch.
|
|
Academic Article
|
Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
|
|
Academic Article
|
Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
|
|
Academic Article
|
Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis.
|
|
Academic Article
|
Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis.
|
|
Academic Article
|
Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.
|
|
Academic Article
|
Expression of ERG protein in prostate cancer: variability and biological correlates.
|
|
Academic Article
|
Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.
|
|
Academic Article
|
FGF23 promotes prostate cancer progression.
|
|
Academic Article
|
Oxidative stress promotes benign prostatic hyperplasia.
|
|
Academic Article
|
The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors.
|
|
Academic Article
|
The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.
|
|
Academic Article
|
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer.
|
|
Academic Article
|
The role of ATP-binding cassette transporter genes in the progression of prostate cancer.
|
|
Academic Article
|
Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.
|
|
Academic Article
|
Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer.
|
|
Academic Article
|
Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
|
|
Academic Article
|
Neuronal Trans-Differentiation in Prostate Cancer Cells.
|
|
Academic Article
|
Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.
|
|
Academic Article
|
Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.
|
|
Academic Article
|
The essential role of GATA transcription factors in adult murine prostate.
|
|
Academic Article
|
Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer.
|
|
Academic Article
|
Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
|
|
Academic Article
|
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.
|
|
Academic Article
|
GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.
|
|
Academic Article
|
MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.
|
|
Academic Article
|
SPOP Mutation Drives Prostate Tumorigenesis In?Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
|
|
Academic Article
|
Cellular interactions of the phosphorylated form of AKT in prostate cancer.
|
|
Academic Article
|
SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
|
|
Academic Article
|
RET Signaling in Prostate Cancer.
|
|
Academic Article
|
RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression.
|
|
Academic Article
|
miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer.
|
|
Academic Article
|
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.
|
|
Academic Article
|
Anatomy and Histology of the Human and Murine Prostate.
|
|
Academic Article
|
Influence of the neural microenvironment on prostate cancer.
|
|
Academic Article
|
TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
|
|
Academic Article
|
MicroRNAs as prognostic markers in prostate cancer.
|
|
Academic Article
|
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers.
|
|
Grant
|
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia
|
|
Grant
|
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
|
|
Grant
|
Mechanisms of Cytokine Induced Lower Urinary Track Pathology
|
|
Grant
|
A novel oncogenic axis in African American prostate cancer
|
|
Grant
|
SPORE in Prostate Cancer
|
|
Grant
|
Cytokines and FGFs in prostate cancer progression
|
|
Grant
|
ROLE OF FIBROBLAST GROWTH FACTORS IN PROSTATE GROWTH
|
|
Academic Article
|
Spatially Restricted Stromal Wnt Signaling Restrains Prostate Epithelial Progenitor Growth through Direct and Indirect Mechanisms.
|
|
Academic Article
|
Comparative analysis of p16 expression among African American and European American prostate cancer patients.
|
|
Academic Article
|
Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer.
|
|
Academic Article
|
Methionine-Homocysteine Pathway in African-American Prostate Cancer.
|
|
Academic Article
|
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer.
|
|
Academic Article
|
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer.
|
|
Academic Article
|
Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity.
|
|
Academic Article
|
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.
|
|
Academic Article
|
Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
|
|
Academic Article
|
Kallikrein gene family as biomarkers for recurrent prostate cancer.
|
|
Academic Article
|
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling.
|
|
Academic Article
|
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
|
|
Academic Article
|
CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis.
|
|
Academic Article
|
MEX3D is an oncogenic driver in prostate cancer.
|
|
Academic Article
|
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.
|
|
Academic Article
|
Expression of Endogenous Retroviral RNA in Prostate Tumors has Prognostic Value and Shows Differences among Americans of African Versus European/Middle Eastern Ancestry.
|
|
Academic Article
|
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics.
|
|
Academic Article
|
Repair-Assisted Damage Detection Reveals Biological Disparities in Prostate Cancer between African Americans and European Americans.
|
|
Academic Article
|
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis.
|
|
Academic Article
|
Lipid Alterations in African American Men with Prostate Cancer.
|
|
Academic Article
|
Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer.
|
|
Academic Article
|
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.
|
|
Academic Article
|
Spatial Profiling of the Prostate Cancer Tumor Microenvironment Reveals Multiple Differences in Gene Expression and Correlation with Recurrence Risk.
|
|
Academic Article
|
Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer.
|
|
Academic Article
|
Persistent organic pollutants promote aggressiveness in prostate cancer.
|
|
Academic Article
|
Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity.
|
|
Academic Article
|
Role of adenosine deaminase in prostate cancer progression.
|
|
Academic Article
|
A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening.
|